226 related articles for article (PubMed ID: 24677715)
21. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
22. Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling.
Liu W; Cao H; Ye C; Chang C; Lu M; Jing Y; Zhang D; Yao X; Duan Z; Xia H; Wang YC; Jiang J; Liu MF; Yan J; Ying H
Nat Commun; 2014 Dec; 5():5684. PubMed ID: 25471065
[TBL] [Abstract][Full Text] [Related]
23. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice.
Hoekstra M; van der Sluis RJ; Kuiper J; Van Berkel TJ
J Nutr Biochem; 2012 Jun; 23(6):622-8. PubMed ID: 21764575
[TBL] [Abstract][Full Text] [Related]
24. MiRNA-145 is involved in the development of resistin-induced insulin resistance in HepG2 cells.
Wen F; Yang Y; Jin D; Sun J; Yu X; Yang Z
Biochem Biophys Res Commun; 2014 Mar; 445(2):517-23. PubMed ID: 24548410
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N
Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.
Hyun J; Wang S; Kim J; Rao KM; Park SY; Chung I; Ha CS; Kim SW; Yun YH; Jung Y
Nat Commun; 2016 Mar; 7():10993. PubMed ID: 27001906
[TBL] [Abstract][Full Text] [Related]
28. miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells.
Pandey AK; Verma G; Vig S; Srivastava S; Srivastava AK; Datta M
Mol Cell Endocrinol; 2011 Jan; 332(1-2):125-33. PubMed ID: 20943204
[TBL] [Abstract][Full Text] [Related]
29. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway.
Liu Y; Zhou X; Xiao Y; Li C; Huang Y; Guo Q; Su T; Fu L; Luo L
J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024
[TBL] [Abstract][Full Text] [Related]
30. Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway.
Li CH; Tang SC; Wong CH; Wang Y; Jiang JD; Chen Y
Eur J Pharmacol; 2018 Apr; 825():107-118. PubMed ID: 29477657
[TBL] [Abstract][Full Text] [Related]
31. De-silencing
Luo L; Jiang W; Liu H; Bu J; Tang P; Du C; Xu Z; Luo H; Liu B; Xiao B; Zhou Z; Liu F
J Mol Endocrinol; 2018 May; 60(4):285-297. PubMed ID: 29555819
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
33. Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.
Zou Z; Liu X; Yu J; Ban T; Zhang Z; Wang P; Huang R; Zheng F; Chang Y; Peng W; Tang Y; Feng X; Zhao Z; Lv X; Huang S; Guo J; Tuo Y; Zhou Z; Liang S
J Hepatol; 2024 Jun; 80(6):834-845. PubMed ID: 38331323
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.
Fu X; Dong B; Tian Y; Lefebvre P; Meng Z; Wang X; Pattou F; Han W; Wang X; Lou F; Jove R; Staels B; Moore DD; Huang W
J Clin Invest; 2015 Jun; 125(6):2497-509. PubMed ID: 25961460
[TBL] [Abstract][Full Text] [Related]
35. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance.
Sud N; Zhang H; Pan K; Cheng X; Cui J; Su Q
J Nutr Biochem; 2017 May; 43():125-131. PubMed ID: 28284064
[TBL] [Abstract][Full Text] [Related]
37. MiR-30c-5p ameliorates hepatic steatosis in leptin receptor-deficient (db/db) mice via down-regulating FASN.
Fan J; Li H; Nie X; Yin Z; Zhao Y; Chen C; Wen Wang D
Oncotarget; 2017 Feb; 8(8):13450-13463. PubMed ID: 28088781
[TBL] [Abstract][Full Text] [Related]
38. Metformin Reduces the Senescence of Renal Tubular Epithelial Cells in Diabetic Nephropathy via the MBNL1/miR-130a-3p/STAT3 Pathway.
Jiang X; Ruan XL; Xue YX; Yang S; Shi M; Wang LN
Oxid Med Cell Longev; 2020; 2020():8708236. PubMed ID: 32104542
[TBL] [Abstract][Full Text] [Related]
39. Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.
Wang XA; Zhang R; She ZG; Zhang XF; Jiang DS; Wang T; Gao L; Deng W; Zhang SM; Zhu LH; Guo S; Chen K; Zhang XD; Liu DP; Li H
Hepatology; 2014 Mar; 59(3):870-85. PubMed ID: 24123166
[TBL] [Abstract][Full Text] [Related]
40. Regulation and mechanism of mouse miR-130a/b in metabolism-related inflammation.
Zheng H; Dong X; Liu N; Xia W; Zhou L; Chen X; Yang Z; Chen X
Int J Biochem Cell Biol; 2016 May; 74():72-83. PubMed ID: 26923288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
